APP and Alzheimer disease: The following study, which was carried out in a murine AD APP/PS1 mice model, showed that synthetic PPAR-α ligands, such as GW7647, decreased lipid peroxidation and inflammation, reduced Aβ deposits, and improved cognition [129].